Marjorie Barrier

489 total citations
13 papers, 422 citations indexed

About

Marjorie Barrier is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Immunology. According to data from OpenAlex, Marjorie Barrier has authored 13 papers receiving a total of 422 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 5 papers in Molecular Biology and 3 papers in Immunology. Recurrent topics in Marjorie Barrier's work include Pulmonary Hypertension Research and Treatments (6 papers), Adipose Tissue and Metabolism (2 papers) and Macrophage Migration Inhibitory Factor (2 papers). Marjorie Barrier is often cited by papers focused on Pulmonary Hypertension Research and Treatments (6 papers), Adipose Tissue and Metabolism (2 papers) and Macrophage Migration Inhibitory Factor (2 papers). Marjorie Barrier collaborates with scholars based in Canada, France and United Kingdom. Marjorie Barrier's co-authors include Sébastien Bonnet, Roxane Paulin, Audrey Courboulin, Steeve Provencher, Jolyane Meloche, Malik Bisserier, Caroline Lambert, Maria Jacob, Pierre Bonnet and Véronique Tremblay and has published in prestigious journals such as Circulation, The FASEB Journal and Hypertension.

In The Last Decade

Marjorie Barrier

13 papers receiving 419 citations

Peers

Marjorie Barrier

PRM

CCM

ONCOL

Junyu Huo China

Isabelle Trinh Canada

Keisuke Okuno Japan

Joke Breyne Belgium

Jun Zou China

Xiujie Liang China

Alexander Weymann United States

Jingmin Zhou China

Kiichiro Jinde Japan

Daphne H.T. IJpelaar Netherlands

Junyu Huo China

Marjorie Barrier

208 ×0.8

PRM

233 ×1.3

96 ×1.0

CCM

161 ×1.8

87 ×2.2

ONCOL

Citations per year, relative to Marjorie Barrier Marjorie Barrier (= 1×) peers Junyu Huo

Countries citing papers authored by Marjorie Barrier

Since Specialization

Citations

This map shows the geographic impact of Marjorie Barrier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marjorie Barrier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marjorie Barrier more than expected).

Fields of papers citing papers by Marjorie Barrier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marjorie Barrier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marjorie Barrier. The network helps show where Marjorie Barrier may publish in the future.

Co-authorship network of co-authors of Marjorie Barrier

This figure shows the co-authorship network connecting the top 25 collaborators of Marjorie Barrier. A scholar is included among the top collaborators of Marjorie Barrier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marjorie Barrier. Marjorie Barrier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Alfazema, Neza, Marjorie Barrier, Sophie Marion de Procé, et al.. (2019). Camk2n1 Is a Negative Regulator of Blood Pressure, Left Ventricular Mass, Insulin Sensitivity, and Promotes Adiposity. Hypertension. 74(3). 687–696. 9 indexed citations

Coan, P. M., Oliver Hummel, Ana Garcia Diaz, et al.. (2017). Genetic, physiological and comparative genomic studies of hypertension and insulin resistance in the spontaneously hypertensive rat. Disease Models & Mechanisms. 10(3). 297–306. 12 indexed citations

Coan, P. M., Marjorie Barrier, Neza Alfazema, et al.. (2017). Complement Factor B Is a Determinant of Both Metabolic and Cardiovascular Features of Metabolic Syndrome. Hypertension. 70(3). 624–633. 28 indexed citations

Barrier, Marjorie, Isabelle Baudrimont, Mathilde Dubois, et al.. (2016). Involvement of Heme Oxygenase-1 in particulate matter-induced impairment of NO-dependent relaxation in rat intralobar pulmonary arteries. Toxicology in Vitro. 32. 205–211. 6 indexed citations

Margaillan, Guillaume, Marjorie Barrier, François Potus, et al.. (2013). miR204/RUNX2 axis regulates HIF‐1α activation in pulmonary arterial hypertension. The FASEB Journal. 27(S1). 2 indexed citations

Meloche, Jolyane, Marjorie Barrier, Sophie Carter, et al.. (2013). Critical Role for the Advanced Glycation End‐Products Receptor in Pulmonary Arterial Hypertension Etiology. Journal of the American Heart Association. 2(1). e005157–e005157. 87 indexed citations

Barrier, Marjorie, Jolyane Meloche, Maria Jacob, et al.. (2012). Today’s and tomorrow’s imaging and circulating biomarkers for pulmonary arterial hypertension. Cellular and Molecular Life Sciences. 69(17). 2805–2831. 14 indexed citations

Courboulin, Audrey, Marjorie Barrier, Pierre Bonnet, et al.. (2012). Plumbagin reverses proliferation and resistance to apoptosis in experimental PAH. European Respiratory Journal. 40(3). 618–629. 56 indexed citations

Courboulin, Audrey, Véronique Tremblay, Marjorie Barrier, et al.. (2011). Krüppel-like Factor 5 contributes to pulmonary artery smooth muscle proliferation and resistance to apoptosis in human pulmonary arterial hypertension. Respiratory Research. 12(1). 128–128. 104 indexed citations

10.

Courboulin, Audrey, Marjorie Barrier, & Sébastien Bonnet. (2011). Abstract 18277: Role of the miR-204/miR-145 Communication in the Etiology of Pulmonary Arterial Hypertension. Circulation. 124(suppl_21). 1 indexed citations

11.

Paulin, Roxane, Audrey Courboulin, Marjorie Barrier, & Sébastien Bonnet. (2011). From oncoproteins/tumor suppressors to microRNAs, the newest therapeutic targets for pulmonary arterial hypertension. Journal of Molecular Medicine. 89(11). 1089–101. 42 indexed citations

12.

Paulin, Roxane, Marjorie Barrier, & Sébastien Bonnet. (2011). New therapeutics for pulmonary arterial hypertension: do gene therapies have translational values?. Clinical Investigation. 1(3). 363–366. 2 indexed citations

13.

Meloche, Jolyane, Roxane Paulin, Audrey Courboulin, et al.. (2011). RAGE-Dependent Activation of the Oncoprotein Pim1 Plays a Critical Role in Systemic Vascular Remodeling Processes. Arteriosclerosis Thrombosis and Vascular Biology. 31(9). 2114–2124. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact